Abstract
The effects of nine essential oils (ylang-wild, lavender, orange, ginger, chamomile, peppermint, sage, nutmeg, and eucalyptus), three known chemical penetration enhancers (tricaprylin, liquid paraffin, and mineral oil), and six plant oils (olive, sunflower, soybean, canola, corn, and grape-seed oil) on the skin permeation of p-aminobenzoic acid were studied using attenuated total reflection-Fourier transform infrared spectroscopy. We applied essential oil creams to the skin of volunteers and then used a high performance liquid chromatograph with a fluorometric detector to evaluate levels of p-aminobenzoic acid and its metabolites in urine that was not pretreated with solvents and directly injected into the liquid chromatograph. After 1–2 days of treatment with different formulations of essential oils, levels of p-aminobenzoic acid and its metabolites were higher in the urine of the participants treated with essential oils than in the urine of the untreated controls.
This is a preview of subscription content, access via your institution.




References
- 1.
Barbieri B, Papadogiannakis N, Eneroth P, Olding LB (1995) Arachidonic acid is a preferred acetyl donor among fatty acids in the acetylation of p-aminobenzoic acid by human lymphoid cells. Biochim Biophys Acta 1257:157–166
- 2.
Barbieri B, Papadogiannakis N, Eneroth P, So’derstedt A, Stain-Malmgren R, Olding LB (1997) P-aminobenzoic acid, but not its metabolite P-acetamidobenzoic acid, inhibits thrombin induced thromboxane formation in human platelets in a non NSAID like manner. Thromb Res 86:127–140
- 3.
Barbieri B, Stain-Malmgren R, Papadogiannakis N (1999) p-Aminobenzoic acid and its metabolite p-acetamidobenzoic acid inhibit agonist-induced aggregation and arachidonic acid-induced [Ca2+](i) transients in human platelets. Thromb Res 95:235–243
- 4.
Barbieri B, Papadogiannakis N, Eneroth P, So’derstedt A, Stain-Malmgren R, Olding LB (1997) P-aminobenzoic acid and its metabolite p-acetamido-benzoic acid suppress agonist induced aggregation of human platelets. FASEB J 11:A315
- 5.
FDA (Federal Drug Administration) (1999) Department of Health and Human Services, 21 CFR Part 352, subpart B-Active Ingredients (Sec. 352.10 sunscreen active ingredients), Sunscreen drug products for over-the-counter human use. Federal Register, Rules and Regulations 64:27687
- 6.
EEC (European Economic Community) (1983) Directive 83/574, No. L332, October 26, 1983, p. 38
- 7.
Kastel R, Rosival IJ, Blahovec I (1994) Simultaneous determination of p-aminobenzoic acid and its metabolites in urine by high-performance liquid chromatography. Biomed Chromatogr 8:294–296
- 8.
Song DJ, Hsu KY (1996) Determination of p-aminobenzoic acid and its metabolites in rabbit plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr B 677:69–75
- 9.
Wang LH, Huang WS, Tai HM (2007) Simultaneous determination of p-aminobenzoic acid and its metabolites in the urine of volunteers, treated with p-aminobenzoic acid sunscreen formulation. J Pharm Biomed Anal 43:1430–1436
- 10.
Dhananjeyan MR, Trendel JA, Bykowski C, Sarver JG, Ando H, Erhardt PW (2008) Rapid and sensitive HPLC assay for simultaneous determination of procaine and para-aminobenzoic acid from human and rat liver tissue extracts. J Chromatogr B 867:247–252
- 11.
Balaguer A, Chisvert A, Salvador A, Herraez M, Diez O (2008) A solid-phase extraction and size-exclusion liquid chromatographic method for polyethylene glycol 25 p-aminobenzoic acid determination in urine: validation for urinary excretion studies of users of sunscreens. Anal Chim Acta 611:220–225
- 12.
Wang LH, Zeng SY (2009) Voltammetric behavior of 4-acetamidohippuric acid and 4-acetamidobenzoic acid at a disposable carbon electrode and their determination in human urine. Collect Czech Chem Commun 74:443–452
- 13.
Kogan A, Garti N (2006) Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci 123:369–385
- 14.
Spernath A (2006) Microemulsions as carriers for drugs and nutraceuticals. Adv Colloid Interface Sci 128:47–64
- 15.
Santus GC, Baker RW (1993) Transdermal enhancer patent literature. J Control Release 25:1–20
- 16.
Williams AC, Barry BW (1989) Essential oils as novel human skin penetration enhancers. Int J Pharm 57:R7–R8
- 17.
Das MK, Bhattacharya A, Ghosal SK (2006) Effect of different terpene-containing essential oils on percutaneous absorption of trazodone hydrochloride through mouse epidermis. Drug Deliv 13:425–431
- 18.
Cal K (2006) Skin penetration of terpenes from essential oils and topical vehicles. Planta Med 72:311–316
- 19.
Zhang LC, Hu JH, Li L, Gao LH, Zhu QG, Li Z (2006) In vivo and in vitro evaluation of essential oils from Ligusticum chuanxiong hort on the transdermal delivery of Flurbiprofen in rbbits. Biol Pharm Bull 29:1217–1222
- 20.
Katayama K, Takahashi O, Matsui R, Morigaki S, Aiba T, Kakemi M, Koizumi T (1992) Effect of l-menthol on the permeation of Indomethacin, Mannitol and Cortisone through excised hairless mouse skin. Chem Pharm Bull 40:3097–3099
Acknowledgments
This work was financially supported by grant NSC 96-2113-M-041-003-MY3 from the National Science Council, Taiwan R. O. C.
Author information
Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, LH., Chen, JX. Study of p-aminobenzoic acid and its metabolites in human volunteers treated with essential oil formulations using attenuated total reflection-Fourier transform infrared spectroscopy and HPLC with fluorometric detection. Microchim Acta 168, 93–98 (2010). https://doi.org/10.1007/s00604-009-0255-y
Received:
Accepted:
Published:
Issue Date:
Keywords
- Essential oil formulations
- Attenuated total reflection-Fourier transform infrared (ATR-FTIR)
- p-aminobenzoic acid (PABA) and its metabolites
- Urine
- Fluorometric detection